Peter H N Oomen Selected Research

von Willebrand Factor

5/2007

Circulating vascular endothelial growth factor is unaffected by acute hyperglycemia and hyperinsulinemia in type 1 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter H N Oomen Research Topics

Disease

1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2013
1	Hypoglycemia (Reactive Hypoglycemia) 06/2012
1	Morbid Obesity 06/2012
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2012
1	Hyperglycemia 05/2007
1	Hyperinsulinism (Hyperinsulinemia) 05/2007
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2007
1	Paraganglioma (Paragangliomas) 01/2006
1	Neoplasms (Cancer) 01/2006
1	Pheochromocytoma 01/2006

Drug/Important Bio-Agent (IBA)

2	Insulin (Novolin)FDA Link 01/2013 - 05/2007
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	fluorodopa F 18IBA 06/2012
1	5-Hydroxytryptophan (5 Hydroxytryptophan)IBA 06/2012
1	Phenylalanine (L-Phenylalanine)FDA Link 06/2012
1	AntigensIBA 05/2007
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2007
1	Blood Glucose (Blood Sugar)IBA 05/2007
1	von Willebrand FactorIBA 05/2007
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2006

Therapy/Procedure

2	Therapeutics 01/2013 - 06/2012
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 06/2012